The role of monoamine oxidase inhibitors in current psychiatric practice
about
Getting the balance right: Established and emerging therapies for major depressive disordersTargeting histone methyltransferases and demethylases in clinical trials for cancer therapyIs increased antidepressant exposure a contributory factor to the obesity pandemic?In vitro Antioxidant and Enzymatic Approaches to Evaluate Neuroprotector Potential of Blechnum Extracts without Cytotoxicity to Human Stem CellsMAOIs - does the evidence warrant their resurrection?World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care.The selegiline transdermal system (emsam): a therapeutic option for the treatment of major depressive disorder8-Benzyltetrahydropyrazino[2,1-f]purinediones: water-soluble tricyclic xanthine derivatives as multitarget drugs for neurodegenerative diseases.A review of the literature on the selegiline transdermal system: an effective and well-tolerated monoamine oxidase inhibitor for the treatment of depression.Selegiline transdermal system: a novel treatment option for major depressive disorder.Reducing the Burden of Difficult-to-Treat Major Depressive Disorder: Revisiting Monoamine Oxidase Inhibitor Therapy.Ketamine as antidepressant? Current state and future perspectives.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders.Irrational Use of Medicines-A Summary of Key Concepts.Recent Advances in Electrochemical Biosensors Based on Enzyme Inhibition for Clinical and Pharmaceutical Applications.Design and Synthesis of New Benzothiazole Compounds as Selective hMAO-B Inhibitors.
P2860
Q24610225-2F34C680-D963-4782-927B-CF8AA47A1359Q26746038-A7066EF7-104C-4C7B-BED3-7082A9E11E02Q26765430-79C79D82-3CA6-43E0-AC87-C5AB9A37586EQ28829842-A2679420-8629-4D8A-BBB0-6497DD2BECF5Q34515817-F853B0BF-373F-4964-9E84-883CD7B82DCBQ34578945-0AC6B056-A106-4B13-A0A4-B320A9C803B3Q35002576-15779DEE-1678-4BC5-B348-58D3892E38D5Q35166780-37EFB15B-E121-4636-94DE-2747083F9B60Q36474119-77B4C02F-D3F6-41F3-AF89-F38E5126486EQ37519729-AF5E13B1-5931-494E-B094-088E8801F7F2Q37533875-824E9FAD-AE33-4F6C-A308-66DFFB6C5409Q37559823-6E190D92-34F4-4EFA-ABE9-9161F058EABCQ38123516-64F20825-A1F4-4843-98EC-5C1565DFA627Q42289325-4D2BD78A-EC7E-4700-8B3C-9B0BD0140A9AQ47190235-8DED7596-165C-4076-8D5A-4E3F2D9605C8Q47919795-405F8DDA-E4EB-47AD-B900-32D40E64780B
P2860
The role of monoamine oxidase inhibitors in current psychiatric practice
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The role of monoamine oxidase inhibitors in current psychiatric practice
@ast
The role of monoamine oxidase inhibitors in current psychiatric practice
@en
The role of monoamine oxidase inhibitors in current psychiatric practice
@nl
type
label
The role of monoamine oxidase inhibitors in current psychiatric practice
@ast
The role of monoamine oxidase inhibitors in current psychiatric practice
@en
The role of monoamine oxidase inhibitors in current psychiatric practice
@nl
prefLabel
The role of monoamine oxidase inhibitors in current psychiatric practice
@ast
The role of monoamine oxidase inhibitors in current psychiatric practice
@en
The role of monoamine oxidase inhibitors in current psychiatric practice
@nl
P2860
P3181
P1476
The role of monoamine oxidase inhibitors in current psychiatric practice
@en
P2093
Karen L Swartz
P2860
P304
P3181
P356
10.1097/00131746-200407000-00005
P407
P577
2004-07-01T00:00:00Z